About
RNA Editing Therapeutics
Areas of Focus
Categories
Boston & New England
Team (71)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
0
As Collaborator
5
Total Enrollment
1,018
By Phase
NA: 2
By Status
COMPLETED: 3UNKNOWN: 1RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06392360Collaborator
Betaine, Exercise Performance, and Gut Permeability
NACompleted
23 participants
Started: Aug 13, 2024 · Completed: Feb 11, 2025
NCT05435144Collaborator
Elderberry for Immune Support
NAUnknown
420 participants
Started: Aug 26, 2022 · Completed: Jun 30, 2023
NCT05908682Collaborator
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
N/ARecruiting
100 participants
Started: Jul 28, 2022 · Completed: Oct 31, 2029
NCT03571477Collaborator
Sleep Apnea : Diagnosis and Monitoring
N/ACompleted
45 participants
Started: Jun 15, 2018 · Completed: Dec 17, 2018
NCT03280368Collaborator
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
N/ACompleted
430 participants
Started: Jun 30, 2014 · Completed: Jan 31, 2020
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...